Recent Presentations
      
August 2010 at the 
National
ACS
Meeting in Boston:
Telling the good from the bad and the ugly:
The challenge of evaluating pharmacophore model performance.
      
July 2010 at 
SMI
ADMET in London:
Integrating Predictive ADMET into Hit to Lead and Optimisation
      
      March 2010 at the 
National ACS
Meeting in San Francisco:
Effects of torsional sampling bias on a multi-objective genetic
algorithm.
      
      October 2009 at the GTCBio Conference on Partnering,
Licensing &
Outsourcing in San Diego CA:
      
Trust but Verify: Getting the
Most Out of ADME/Tox Screening.
      
      March 2009 at the ACS National Meeting in Salt Lake City
UT:
 
At
what point does docking
morph into 3D QSAR?
      
November 2008 at ANNIE 2008 in St. Louis MO: 
      
To Pareto or Not to Pareto,
That is the Question.
      
August 2008 at the ACS National Meeting in Philadelphia PA:
      
Looking for some good
vibrations.
      
June 2008 at the 8th ICCS in Noordwijkerhout, the Netherlands (Poster):
      
      
The Effect of Structural
Redundancy on Virtual Screen Performance.
      
April 2008 at the ACS National Meeting in New Orleans LA:
    
Localizing
uncertainty in PLS predictivity; and
      
Both
sides now: An intimate
perspective on collaborations.
      
August 2007 at the ACS National Meeting in Boston MA:
      
    The role of
alignment in 3D QSAR; and
      
Validation and the downside of
the law of large numbers
      
      June 2007 at the 4th Joint Sheffield Conference on
Cheminformatics:
      
When Worlds Collide: Looking
for Answers to "The Alignment Problem"
      
March 2007 at the ACS National Meeting in Chicago IL:
      
    Generalized
knowledge-based approach to quickly generating diverse but
        
 energetically representative ensembles of ligand conformers.
      
November 2006 at ANNIE 2006 in St. Louis MO:
      
Sex and the single GA.
      
October 2006 at eCheminfo Community InterAction meeting in Philadelphia
PA:
    
Challenges of
ADME/Tox Prediction.
      
September 2006 at the ACS National Meeting in San Francisco CA:
    
What's a drug
designer to do?; and
      
    Using
pharmacophoric and pharmacosteric multiplets to characterize binding
sites.
      
September 2005 at the ACS National Meeting in Atlanta GA:
      
Putting the "Structure" in
(Q)SAR into context.